GSK’s RSV, shingles vaccines show on-par immune response in joint trial
The trial testing the immune response of co-administration of GSK’s blockbuster vaccines, Shingrix and Arexvy, in adults over 50 years of age, met the main goal of the study.
If you are not happy with the results below please do another search
The trial testing the immune response of co-administration of GSK’s blockbuster vaccines, Shingrix and Arexvy, in adults over 50 years of age, met the main goal of the study.
The deal gives Organon VTAMA cream, a novel, non-steroidal topical therapy approved for treatment of plaque psoriasis in adults and is under FDA review for an additional indication to treat atopic dermatitis.
The experimental device “will enable even those who have lost both eyes and their optic nerve to see,” Musk said in a post on X.
U.S. Senator Bernie Sanders said on Tuesday he received confirmation from major generic pharmaceutical companies that they could sell copycat versions of Novo Nordisk’s diabetes drug for less than $100 a month.
Rooted in Hill Holliday’s health legacy, Hill Holliday Quest fuses behavioral science, strategic insight, creative, social and media to design human-centric solutions that resonate and drive behavior change.
Imre has made two key leadership appointments strengthening a historically strong Client Experience (CX) practice. This comes as the brand engagement agency continues its aim at increasing agency-of-record assignments among healthcare and specialty pharmaceutical brands.
The promotion demonstrates The Bloc’s ongoing commitment to growth and innovation in the European health communications market.
Boehringer Ingelheim’s investigational compound nerandomilast, which targets the PDE4B enzyme involved in fibrosis and inflammation in the lungs, met its primary endpoint in a late-stage study.
In metabolic dysfunction-associated steatotic liver disease, a retrospective analysis shows that patients on GLP-1 receptor agonists are 14% less likely to progress to cirrhosis.
According to GlobalData’s Pharmaceutical Intelligence Center, as of September 16, in Japan there are 14 gene therapies in the preclinical stage of development targeting eight different therapy areas with a significant focus on oncology, ophthalmology, hematological disorders, and the central nervous system.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlySettingsWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds: